Equities

CompuGroup Medical SE & Co KgaA

  • Add to watchlist
  • Add to portfolio
  • Add an alert

CompuGroup Medical SE & Co KgaA

Actions
  • Price (EUR)27.00
  • Today's Change0.00 / 0.00%
  • Shares traded238.00
  • 1 Year change+19.89%
  • Beta0.8862
Data delayed at least 15 minutes, as of Feb 13 2026 07:37 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

CompuGroup Medical SE & Co. KGaA is a Germany-based company engaged in the enterprise software development. The Company focuses on providing software solutions to healthcare institutions. The activities are divided into six segments: Ambulatory Software Services (AIS), providing practice management software and medical records; Pharmacy Information Systems (PCS), including integrated clinical, administrative and financial software applications for pharmacies; Hospital Information Systems (HIS), such as laboratory and special care information systems; Communication & Data (C&D), offering software interfaces for pharmaceutical and medical equipment manufacturers; provides Picture Archiving and Communication Systems (PACS); Workflow & Decision Support (WDS), delivering software for management support aimed at healthcare payers, such as health insurers and managed care companies, and Internet Service Provider (ISP), providing Internet for healthcare providers.

  • Revenue in EUR (TTM)1.17bn
  • Net income in EUR18.25m
  • Incorporated2020
  • Employees8.17k
  • Location
    CompuGroup Medical SE & Co KgaAMaria Trost 21KOBLENZ 56070GermanyDEU
  • Phone+49 26180000
  • Fax+49 26 180001166
  • Websitehttps://www.cgm.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
COP:HAM since
announced
Transaction
value
perimed Fachbuch Verlag Dr med Straube GmbHDeal completed07 Apr 202507 Apr 2025Deal completed20.21%--
Data delayed at least 15 minutes, as of Feb 13 2026 07:37 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
IVU Traffic Technologies AG149.38m13.43m337.55m1.07k24.703.8618.742.260.77130.77138.434.940.96314.573.13139,737.108.667.6912.7111.8081.7977.998.999.381.98233.690.1876--9.138.535.832.628.6311.84
Init Innovation In Traffic Systems SE314.43m16.65m452.80m1.56k26.643.4413.621.441.691.6931.8713.101.003.513.97250,542.605.226.158.449.0537.9737.165.217.241.025.730.440142.5726.0311.171.846.4226.2314.87
Mensch und Maschine Software SE232.87m30.11m655.95m1.20k21.278.2714.982.821.801.8013.904.621.115.885.62212,667.6015.9815.8829.2725.7175.2552.1114.359.400.890430.190.329395.061.105.795.6112.8317.1716.83
innoscripta SE78.81m32.68m658.00m330.0020.1314.2820.008.353.273.277.884.611.372.292.91303,099.0056.99--62.71--97.14--41.47--12.25--0.1126--64.34--144.27------
CHAPTERS Group AG131.62m-18.63m703.72m1.08k--3.1378.915.35-0.782-0.7825.289.580.30852.339.03131,616.40-4.63-3.28-8.08-4.7583.35---15.00-11.500.3923-5.920.2611--56.39308.75-79.47------
PSI Software SE287.01m-23.12m707.95m2.37k--9.97--2.47-1.48-1.4818.514.520.98386.916.60117,918.70-7.921.63-13.192.3787.2485.04-8.051.781.18-5.350.557077.59-3.352.98-2,862.52--5.38--
TeamViewer SE730.84m115.59m856.74m1.91k7.146.275.201.170.73430.73434.640.83570.5435--46.28460,805.208.607.7518.0111.9887.3886.5715.8216.23--3.500.88380.007.1411.477.953.45-20.24--
ATOSS Software SE-100.00bn-100.00bn1.36bn825.00--20.02----------4.27----------30.27--44.30--74.98--22.24----0.09980.6012.8519.0427.0527.400.415527.29
CompuGroup Medical SE & Co KgaA1.17bn18.25m1.45bn8.17k77.542.2211.191.240.34820.348222.5312.160.595611.535.70134,055.800.96433.421.204.2583.6184.631.625.591.113.700.565745.23-2.849.12-24.65-12.077.54-36.90
AUTO1 GROUP SE7.74bn79.43m4.16bn5.55k51.545.9931.610.53740.36530.365335.663.143.329.1219.391,394,528.003.40-12.374.62-16.0111.979.501.03-3.321.485.860.6695--14.8112.53117.94--34.85--
Scout24 SE-100.00bn-100.00bn5.02bn1.12k--------------------------5.44--5.88--101.62--29.01------59.6211.2410.12-9.3320.619.237.72
Zalando SE11.57bn239.00m5.42bn16.12k22.301.918.820.46810.91960.919647.0410.721.363.1312.08756,071.602.802.325.914.3440.3740.512.061.640.586716.270.33430.004.2310.28202.5320.29-7.57--
Data as of Feb 13 2026. Currency figures normalised to CompuGroup Medical SE & Co KgaA's reporting currency: Euro EUR

Institutional shareholders

8.58%Per cent of shares held by top holders
HolderShares% Held
DWS Investment GmbHas of 28 Feb 20251.49m2.78%
Barclays Bank Plc (Private Banking)as of 23 Jan 20251.37m2.56%
Syquant Capital SASas of 30 Jun 20251.11m2.06%
Apo Asset Management GmbHas of 30 Apr 2024205.03k0.38%
Monega Kapitalanlagegesellschaft mbHas of 30 Apr 2025172.54k0.32%
Cr�dit Mutuel Asset Management SAas of 28 Mar 2024100.00k0.19%
HANSAINVEST Hanseatische Investment-GmbHas of 30 Sep 202575.72k0.14%
Momentum Global Investment Management Ltd.as of 31 Dec 202442.60k0.08%
TBF Global Asset Management GmbHas of 30 Sep 202520.00k0.04%
Axxion SA (Luxembourg)as of 31 Mar 202518.50k0.03%
More ▼
Data from 30 Dec 2025 - 30 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.